Back to Directory
Last Updated: 06/05/2026
272Bio
South East England
Founded 2019
VHH single-domain antibody therapeutics for companion animals and livestock
272Bio is a biotechnology company developing biotherapeutic treatments for animal health applications across livestock and companion animals.
The company applies novel antibody engineering technologies, including VHH-based biologics, to create targeted and cost-effective therapies for veterinary diseases.
272Bio focuses on advancing next-generation biologics platforms to improve treatment outcomes and accessibility within the global animal health and veterinary medicine markets.